Abstract
In this issue of Immunity, Boller et al. (2016) show that a C-terminal domain of EBF1 is required for chromatin binding and induction of DNase I hypersensitive sites. These properties mark EBF1 as a pioneer factor in B cell development and demonstrate a role for non-DNA binding domains in this process.
Original language | English (US) |
---|---|
Pages (from-to) | 516-518 |
Number of pages | 3 |
Journal | Immunity |
Volume | 44 |
Issue number | 3 |
DOIs | |
State | Published - Mar 15 2016 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases
- Immunology